Kasandra Belanger
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Optimization of synthetic human VH affinity and solubility through in vitro affinity maturation and minimal camelization.
Journal: Protein science : a publication of the Protein Society
Published: November 27, 2024
Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria.
Journal: Frontiers in drug delivery
Published: December 22, 2023
Immunogenicity and humanization of single-domain antibodies.
Journal: The FEBS journal
Published: February 04, 2021
High-efficacy, high-manufacturability human VH domain antibody therapeutics from transgenic sources.
High-efficacy, high-manufacturability human VH domain antibody therapeutics from transgenic sources.
Journal: Protein engineering, design & selection : PEDS
Published: December 02, 2020
Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.
Journal: Nature communications
Published: November 11, 2019
Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS Diseases.
Journal: Antibodies (Basel, Switzerland)
Published: March 01, 2019
Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate with the Viral Envelope as a Type I Integral Membrane Protein.
Journal: Journal of virology
Published: August 30, 2017
Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G.
Journal: The Journal of general virology
Published: June 07, 2015
Last Updated: 09/26/2026